One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...

The number of U.S. adults with severe obesity increased from 2013 to 2023, according to a research letter published online Feb. 13 in the Journal of the American Medical Association.

Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.

Greaux Healthy—a public service initiative powered by Pennington Biomedical Research Center, in partnership with the State of Louisiana—has released the Childhood Obesity Prevention, Evaluation and ...

Eli Lilly wants to take big swings in Alzheimer’s, ALS, chronic pain and other difficult diseases after its success in ...

Recent senatorial hearings reflect the move to convict UPFs (ultra-processed food) as the culprit responsible for society’s obesity and juvenile metabolic diseases “epidemics” while deflecting focus ...

Shares in Novo Nordisk were up nearly 12% today – hiking its valuation to more than $280 billion – after it reported new clinical data with one of its obesity drug candidates. The new results ...

Developed in alignment with the 2023 American Academy of Pediatrics (AAP) clinical practice guidelines, the toolkit synthesizes the latest scientific evidence and real-world strategies to support ...